Limelight is a privately held, multi-platform, multi-disease biopharmaceutical company headquartered in Philadelphia, PA and Cambridge, MA.
Limelight Bio is pioneering new therapies that break down barriers of current genetic medicine to bring hope to as many patients and families as possible. Since 2017, Limelight has been developing proprietary technologies, advanced targets, and leading drug candidates designed to overcome key limitations of current gene therapy and gene editing approaches.
Company Details
- Employees
- 5
- Founded
- 2016
- Address
- 3401 Grays Ferry Ave, Philadelphia,pennsylvania 19146,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.limelightbio.org
- Keywords
- See all employees.
- HQ
- Philadelphia, Pennsylvania
Limelight Bio Questions
Limelight Bio's website is https://www.limelightbio.org
Limelight Bio's LinkedIn profile is https://www.linkedin.com/company/limelight-bio-inc
Limelight Bio has
5 employees.
View email and phone details for 5
employees at Limelight Bio.
Limelight Bio's industry is
Biotechnology Research
Limelight Bio's top competitors are
Ribonova, Inc.,
B₊labs,
Seneca Therapeutics, Inc.,
X-Synergy Group,
Volta Therapeutics,
Epiphany Biotech,
Talee Bio,
Interius Biotherapeutics,
Kh Supply Chain Llc,
Polycore Therapeutics, Inc..
Limelight Bio's categories are Biotechnology Research
Limelight Bio's founding year is 2016
